RE-BVS – Piemonte Repository

Sfoglia per AUTORE
FONTANA MC
Collezione AOU Città della Salute di Torino

Items : 3

Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients. in Leukemia research / Leuk Res. 2021 Feb;101:106497. doi: 10.1016/j.leukres.2020.106497. Epub 2020 Dec 25.

2021
AOU Città della Salute di Torino

Paolini S; Curti A; Bonifazi F; Testoni N; Baldazzi C; Cristiano G; Raffini M; Fontana MC; Parisi S; Ottaviani E; Bochicchio MT; Sartor C; Abbenante MC; Ragaini S; Olivi M; Talami A; Bertamini L; Nanni J; Martinelli G; De Polo S; Marconi G; Cavo M; Papayannidis C;

Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a. in Biomedicines / Biomedicines. 2021 Apr 6;9(4):388. doi: 10.3390/biomedicines9040388.

2021
AOU Città della Salute di Torino

Fontana MC; Nanni J; Ghelli Luserna di Rorà A; Petracci E; Padella A; Ghetti M; Ferrari A; Marconi G; Soverini S; Iacobucci I; Papayannidis C; Curti A; Audisio E; Giannini MB; Rondoni M; Lanza F; Cavo M; Martinelli G; Simonetti G;

MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia. in European journal of haematology / Eur J Haematol. 2020 Jul;105(1):47-55. doi: 10.1111/ejh.13406. Epub 2020 Apr 7.

2020
AOU Città della Salute di Torino

Marconi G; Talami A; Abbenante MC; Sartor C; Parisi S; Nanni J; Bertamini L; Ragaini S; Olivi M; de Polo S; Cristiano G; Fontana MC; Bochicchio MT; Ottaviani E; Arpinati M; Sessa M; Baldazzi C; Caso L; Testoni N; Baccarani M; Bonifazi F; Martinelli G; Paolini S; Cavo M; Papayannidis C; Curti A;